GlassScriptPhysician profile
Holly Knuckles
NPI 1306972617
$910.34
in general payments reported to CMS, 2019-2025
19 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $283 · 2022: $392 · 2023: $59.93 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $137 · Food and Beverage: $97.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $137.01 |
| Food and Beverage | $97.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $244.03 | 2021-2022 | |
| Medical Device Business Services, INC. | $156.49 | 2025 | Stratafix |
| Boston Scientific Corporation | $156.29 | 2021-2022 | |
| Pfizer INC. | $75.18 | 2021-2025 | |
| Smith+Nephew, INC. | $31.55 | 2021 | |
| Silk Road Medical, INC. | $30.99 | 2022 | |
| Shockwave Medical, INC | $30.10 | 2022 | |
| Angiodynamics, INC. | $27.86 | 2022-2023 | Alphavac |
| Cardiovascular Systems INC. | $17.85 | 2022 | |
| Cardiva Medical, INC. | $17.04 | 2023 | Cardiva Vascade 6/7f Vcs |
| Cvrx, INC. | $16.47 | 2023 | Barostim Neo System |
| Alexion Pharmaceuticals, INC. | $16.12 | 2021 | |
| Terumo Medical Corporation | $14.70 | 2022 | |
| Novo Nordisk INC | $14.13 | 2022 | |
| Bard Peripheral Vascular, INC. | $12.71 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avinger INC. | $12.68 | 2022 | |
| Lemaitre Vascular, INC. | $12.59 | 2023 | Artegraft Vascular Graft |
| Novartis Pharmaceuticals Corporation | $12.16 | 2022 | |
| Venturemed Group, INC. | $11.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Holly Knuckles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.